Subscribe to our Newsletters !!

    Human trial

    Johnson and Johnson begins human safety preliminaries

    Johnson & Johnson on Thursday kicked off US human safety trials because of its COVID-19 vaccine after releasing details of a research in monkeys that showed its best-performing vaccine candidate offered strong defense in a single dose. When subjected to this virus, six out of six animals who obtained the vaccine candidate proved completely protected